Blockchain Registration Transaction Record
Calidi Biotherapeutics Pioneers Next-Gen Cancer Therapies
Calidi Biotherapeutics (CLDI) advances cancer treatment with engineered virus platform, featured in NetworkNewsWire. Explore groundbreaking therapies for hard-to-treat cancers.

This news is crucial as it highlights a significant leap forward in the fight against cancer, offering hope for patients with hard-to-treat cancers and potentially autoimmune disorders. Calidi Biotherapeutics' innovative approach could lead to more effective and safer treatments, addressing a critical need in global healthcare. The company's advancements not only represent a potential breakthrough in oncology but also underscore the importance of biotech innovation in solving complex medical challenges.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x0fa139e9d9d614703162efe6705e70b435315dbb66243c7f41a3725977fc3792 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | cornXiCm-18f3bf91a1a28d732f0cf7bd8f1268ac |